EdgeNewswire

News Center

Featured News

Regentis Biomaterials (NYSE American: RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process

July 15, 2026

Recent News

July 15, 2026

Regentis Biomaterials (NYSE American: RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process

July 15, 2026

Greenland Mines (NASDAQ: GRML) Reports 31% Increase in Indicated Palladium Equivalent Resource at Skaergaard Project

July 15, 2026

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Expands Clinical Development of Neuroprotective Therapy

July 15, 2026

SS Innovations International (NASDAQ: SSII) Appoints Sarah Romano as Chief Financial Officer

July 15, 2026

Now is Your Moment: Huawei Unlocks New Possibilities for Every Moment Through All-Scenario Innovation

July 15, 2026

Fitch Ratings assigns first-time credit rating to HDBank, recognises its strong financial profile

July 13, 2026

VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development

July 13, 2026

Wrap Technologies (NASDAQ: WRAP) Opens Third Quarter With $1.2M in International Orders 

July 11, 2026

Fujifilm Launches “FUJINON Lens GF19-35mmT3.5 PZ OIS WR”

July 10, 2026

Greenland Mines (NASDAQ: GRML) Secures Australian Patent for Klotho Gene Therapy Platform

July 9, 2026

Datavault AI (NASDAQ: DVLT) Secures USPTO Allowance for Blockchain-Based Patent Targeting Naked Short Selling

July 9, 2026

Beeline Holdings (NASDAQ: BLNE) Brings AI Platform In-House with MagicBlocks Acquisition

July 9, 2026

VERAXA Biotech (NASDAQ: VRXA) Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnership

July 9, 2026

SS Innovations International (NASDAQ: SSII) Is ‘One to Watch’

July 8, 2026

Greenland Mines (NASDAQ: GRML) Accelerates Rare Earth Development at Sarfartoq Project

July 7, 2026

Wrap Technologies (NASDAQ: WRAP) Launches WrapShield Autonomous Defense and Public Safety Platform

More News

March 30, 2026

Mandarin Oriental Conservatorium, Amsterdam Unveils Signature Fan by Studio Drift

March 30, 2026

Jetstar takes off for the first time from the Sunshine Coast to Bali and Singapore with sale fares from $209^

March 30, 2026

Cathay and Rugby For Good launch inaugural "Cathay GET SET MOVE Carnival"

Promoting physical and mental wellbeing to students through rugby

March 30, 2026

Evo Tech Launches Evolution AI Platform for National Security Applications

Evo Tech’s new Evolution AI platform empowers national security agencies to analyze massive data streams rapidly, detect threats in real time, and automate responses. It offers adaptive intelligence that improves decision accuracy and operational efficiency for defense and critical infrastructure organizations.

March 30, 2026

20 years in, SmartBuyGlasses reaches 2 million customers worldwide

After two decades of founder-led growth, SmartBuyGlasses has built a vertically integrated global operation spanning more than 30 countries, with in-house opticians, proprietary technology, and over 100,000 products from more than 300 designer brands, all without external funding.

March 30, 2026

Dental Fluoride Treatment Market size to Reach USD 17.29 Billion by 2031 Amid Rising Preventive Care Focus and Shift Toward Topical Solutions

Mordor Intelligence has published a new report on the dental fluoride treatment market, offering a comprehensive analysis of trends, growth drivers, and future projections.

March 30, 2026

Singapore Office Market Demonstrates Resilience with Fifth Consecutive Quarter of Rental Growth

Core CBD Grade A rents rise 0.8% q-o-q to S$12.40 psf/month in Q1 2026. Vacancy shrinks to record low of 3.3%. Growth expected to persist in spite of global headwinds.

March 27, 2026

YesAsia Holdings Achieves Record-Breaking Revenue and Net Profit in 2025

March 27, 2026

Lixte Biotech (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Position Through Liora Technologies Partnership

Lixte Biotech Holdings (NASDAQ: LIXT) is advancing the frontiers of precision oncology, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects. By focusing on […]

March 26, 2026

Soligenix (NASDAQ: SNGX) Receives EU Orphan Drug Designation For Dusquetide In Behçet Disease

Soligenix (NASDAQ: SNGX) announced the European Commission has granted orphan drug designation to dusquetide (SGX945) for the treatment of Behçet Disease, following a positive recommendation from the European Medicines Agency and supportive Phase 2a data demonstrating biological efficacy and safety. The designation provides up to 10 years of market exclusivity in the European Union and adds to existing FDA orphan and […]

19 20 21 22 ...
EdgeNewswire

EdgeNewswire distributes your news to a targeted and established network of journalists and media outlets. We help build visibility and credibility for your organization and brand through trusted media coverage.

Copyright © 2024 - 2025   EdgeNewswire – Cutting Edge Press Release Distribution Services. All Rights Reserved.